共 50 条
- [1] MANAGEMENT OF BLOOD-LOSS IN JEHOVAH-WITNESSES - RECOMBINANT-HUMAN-ERYTHROPOIETIN HELPS BUT IS EXPENSIVE [J]. BRITISH MEDICAL JOURNAL, 1995, 311 (7013): : 1115 - 1116
- [2] THE USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PRETERM INFANTS [J]. INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1995, 2 (02): : 97 - 103
- [4] DOUBLE-BLIND TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PRETERM INFANTS [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1993, 68 (03): : 291 - 296
- [6] DOUBLE-BLIND TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PRETERM INFANTS [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1993, 69 (05): : 542 - 542
- [9] COMBINED APROTININ AND ERYTHROPOIETIN USE FOR BLOOD CONSERVATION - RESULTS WITH JEHOVAH-WITNESSES [J]. ANNALS OF THORACIC SURGERY, 1994, 58 (05): : 1397 - 1403
- [10] Recombinant Human Erythropoietin Therapy in Critically Ill Jehovah's Witnesses [J]. PHARMACOTHERAPY, 2008, 28 (11): : 1383 - 1390